NDATF (NDatalyze) ROCE %: -92.54% (As of Feb. 2026)


What is NDatalyze ROCE %?

NDatalyze NDATF ROCE % is -92.54% as of Feb. 2026.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. NDatalyze's annualized ROCE % for the quarter that ended in Feb. 2026 was -92.54%.

NDatalyze  (OTCPK:NDATF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

NDatalyze ROCE % Related Terms

NDatalyze ROCE % Historical Data

* Premium members only.

The historical data trend for NDatalyze's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NDatalyze ROCE % Chart

NDatalyze Annual Data
Trend Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
ROCE %
Get a 7-Day Free Trial -96.18 -107.03 -60.88 -89.47 -47.31

NDatalyze Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -202.67 -26.05 -38.15 -31.85 -92.54

NDatalyze ROCE % Calculation

NDatalyze's annualized ROCE % for the fiscal year that ended in Feb. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Feb. 2026 )  (A: Feb. 2025 )(A: Feb. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Feb. 2026 )  (A: Feb. 2025 )(A: Feb. 2026 )
=-0.145/( ( (0.392 - 0.017) + (0.251 - 0.013) )/ 2 )
=-0.145/( (0.375+0.238)/ 2 )
=-0.145/0.3065
=-47.31 %

NDatalyze's ROCE % of for the quarter that ended in Feb. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Feb. 2026 )  (Q: Nov. 2025 )(Q: Feb. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Feb. 2026 )  (Q: Nov. 2025 )(Q: Feb. 2026 )
=-0.248/( ( (0.312 - 0.014) + (0.251 - 0.013) )/ 2 )
=-0.248/( ( 0.298 + 0.238 )/ 2 )
=-0.248/0.268
=-92.54 %

(1) Note: The EBIT data used here is four times the quarterly (Feb. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -92.54% mean?
NDatalyze (NDATF) has a ROCE % of -92.54% as of Feb. 2026.
Is NDatalyze's ROCE % too high?
NDatalyze's current ROCE % is -92.54%.
How does NDatalyze's ROCE % compare to VEEV and BTSG?
NDatalyze's ROCE % of -92.54% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.43. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.43, based on 645 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NDatalyze's current ROCE % is -92.54%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NDatalyze stock overvalued right now?
Based on GuruFocus' analysis, NDatalyze (NDATF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.05, compared to a current price of $0.08 — trading 60% above its estimated fair value. The current ROCE % is -92.54%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For NDatalyze (NDATF), the current ROCE % is -92.54% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NDatalyze Business Description

Other Exchanges NDAT:Canada
Address 707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6
NDatalyze Corp develops technologically-based, specialized products, databases, and applications. The YMI division is developing a data-driven consumer mHealth application designed to predict current and future health conditions to lessen the cost of health services and decrease the load on health care services. The MLdelic division is providing a database platform that may be used to predict potential benefits associated with the use of entheogenic compounds within the mental health sector. The Medxtractor division manufactures small-scale bio-extractors that are used to extract essential oils from botanical materials.